# Nuclide record action-1 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/action-1/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "action-1", "NCT05477576" ;
  schema:name "ACTION-1"@en ;
  schema:description "Tests whether an actinium alpha-radioligand rescues neuroendocrine tumours after lutetium therapy fails."@en ;
  schema:url <https://nuclide.cc/trials/action-1/> ;
  schema:dateModified "2026-10-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05477576>, <https://jnm.snmjournals.org/content/67/8/1239> ;
  nuclide:status "active" ;
  nuclide:phase "3" ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/ac-225/> ;
  nuclide:indications <https://nuclide.cc/indications/neuroendocrine/> ;
  nuclide:technologies <https://nuclide.cc/technologies/targeted-alpha-therapy/> ;
  nuclide:drugs <https://nuclide.cc/drugs/ryz101/>, <https://nuclide.cc/drugs/lutathera/> .